VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
ASX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ASXASE Technology Holding Co., Ltd.
$39.86$86.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksASXCash Flow

ASE Technology Holding Co., Ltd. (ASX) Cash Flow Statement

27Y historyFree accessUpdated daily

Operating cash flow of $47.0B in 2026Q2 was 2.23 times net income, but aggressive capex (41.8% of revenue) drove free cash flow to -$32.8B, indicating a heavy reinvestment phase.

Income StatementBalance SheetCash FlowRatios

ASX Cash Flow Statement

Annual statement

ASX Cash Flow Statement

ASE Technology Holding Co., Ltd. (ASX) cash flow statement — 27-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Cash from Operations330.06B143.03B84.74B104.56B105.21B78.79B69.52B65.46B51.68B47.27B51.19B55.36B45.65B40.58B32.58B32.17B34.36B15.55B30.69B28.08B34.64B20.97B18.73B13.29B11.34B11.71B17.64B7.73B
Operating CF Margin %-22.04%13.94%18.21%15.49%13.96%15.28%16.02%13.67%16.41%18.57%18.84%17.55%18.74%17.02%16.97%19.62%18.66%31.41%28.02%34.37%24.35%25.9%23.22%24.82%30.51%34.67%23.27%
Operating CF Growth %1233.35%68.79%-18.96%-0.62%33.54%13.32%6.21%26.67%9.33%-7.67%-7.52%21.26%12.49%24.57%1.28%-6.37%120.96%-49.34%9.3%-18.93%65.2%11.96%40.88%17.21%-3.13%-33.64%128.37%-
Net Income61.08B40.66B33.15B31.3B62.86B63.29B26.33B16.66B25.73B22.8B21.74B20.2B23.96B15.45B12.9B14.04B17.01B6.55B6.37B12.05B17.82B-5.17B3.53B2.74B129.36M-2.14B5.84B7.93B
Depreciation & Amortization56.27B67.44B59.95B56.25B55.01B53.25B48.37B49.32B43.09B28.84B29.5B30.61B26.71B25.08B23.13B23.47B18.42B17.14B17.84B16.47B14.54B15.95B15.05B13.57B13.13B11.82B9.15B6.17B
Stock-Based Compensation338.59M000000000000000000000000000
Deferred Taxes00000000000000565.43M470.95M51.72M223.2M725.98M2.01B483.6M-493.43M-1.6B-1.19B-1.13B-401.75M-226.89M-349.32M
Other Non-Cash Items264.9B11.58B-2.78B-2.07B12.18B-6.82B2.15B-777.68M-3.8B1.85B5.89B2.68B3.77B3.33B1.68B2.25B1.28B505.72M2.21B3.29B-800.07M9.52B5.31B211.44M66.02M-473.53M-682.22M-4.42B
Working Capital Changes-46.9B23.35B-5.59B19.08B-24.84B-30.94B-7.32B261.8M-13.35B-6.23B-5.94B1.87B-8.79B-3.28B-5.7B-8.07B-2.4B-8.87B3.53B-5.74B2.59B1.15B-3.57B-2.84B-1.21B337.73M-93.54M-1.61B
Change in Receivables-45.38B-13.05B-14.09B16.62B-1.34B-29.37B-8.64B-419M-9.55B-4.36B-6.41B8.33B-9.84B-5.69B-6.35B1.17B-1.73B-6.41B7.96B-5.48B4.78B-2.71B-1.12B00000
Change in Inventory-26.17B-8.56B1.82B25.06B-21.94B-23.1B-12.94B1.39B-9.42B-2.88B3.17B-5.32B-8.32B-3.19B-2.4B-5.22B-2.01B-1.47B151.69M-314.58M1.37B89.49M-4.51B-1.56B-364.07M477.9M-796.62M-452.85M
Change in Payables30.02B10.56B7.85B-8.92B-5.52B13.52B13.39B-1.01B7.12B4.71B1.67B-1.32B6.51B4.65B2.95B-3.27B1.54B3.68B-4.5B655.1M-3.69B3.21B1.43B00000
Cash from Investing-583.2B-166.55B-86.53B-54.87B-75.98B-54.95B-64.15B-65.95B-141.15B-16.2B-46.35B-56.45B-29.3B-29.5B-43.29B-32.76B-33.47B-15.53B-37.62B-17.94B-22.18B-13.81B-29.62B-18.55B-13.2B-15.18B-33.55B-12.57B
Capital Expenditures-571.8B-162.15B-83.86B-54.16B-74.88B-73.63B-61.55B-58.07B-44.76B-25B-27.3B-31.91B-40.54B-29.01B-38.97B-31.28B-31.85B-11.12B-19.33B-17.7B-18.01B-16.09B-27.41B-17.52B-12.69B-11.57B-30.06B-10.05B
CapEx % of Revenue80.01%24.99%13.8%9.43%11.03%13.04%13.53%14.21%11.84%8.68%9.91%10.86%15.59%13.4%20.35%16.5%18.19%13.34%19.79%17.66%17.87%18.69%37.91%30.59%27.77%30.14%59.07%30.26%
Acquisitions-944.62M0-1.62B849.06M-362.67M19.06B-6B-11.62B-105.06B8.19B-2.47B9.49B10.47B99.62M220.32M-832.84M-5.49B90.47M-27.21B-494.64M414.98M1.74B-629.1M-20.95M-2.09B00-7.4B
Investments----------------------------
Other Investing-10.19B-4.4B-1.2B216.4M-531.13M-242.63M1.2B26.75M2.55B268.7M-1.42B-281K-487.24M-98.46M-687.82M-731.86M-4.38M-1B-367.17M-683.5M4.91B1.68B-1.4B-768.52M-1.04B-484.23M10.56M4.88B
Cash from Financing277.38B45.52B-6.53B-47.97B-62.11B524.22M-14.98B5.56B93.85B-18.92B-18.07B-284.13M-12.88B11.6B7.55B-350.48M1.58B-2.7B14.34B-8.41B-12.6B-101.74M8.81B4.21B531.76M603.5M17.58B8.72B
Debt Issued (Net)90.31B67.41B16.83B-10.67B-31.57B22.13B-7.9B15.56B103.55B-19.48B-7.01B19.61B-4.29B15.04B7.88B5.88B3.78B612.52M23.55B-698.84M-16.02B-1.02B10.82B2.08B2.3B3.79B5.21B8.51B
Equity Issued (Net)3.4B3.5B1.13B1.16B874.29M-2.77B1.85B1.14B1.22B11.63B998.51M-4.2B1.52B4.4B311.63M-2.23B-636.12M-1.04B-888.92M1.01B851.54M330.45M41.09M0004.15B0
Dividends Paid-96.19B-23.16B-22.92B-37.34B-30.36B-17.91B-8.13B-10.5B-10.81B-11.12B-12.28B-15.86B-10.1B-7.72B-4.19B-3.95B-1.8B-2.5B-9.13B-6.87B0-404.39M000000
Share Repurchases0000-208.14M-5.48B00-72.64M00-5.53B000-2.84B-1.1B-1.28B-1.14B000000000
Other Financing279.86B-2.23B-1.56B-1.12B-1.05B-920.92M-794.24M-641.13M-115.99M43.4M220.53M165.06M-2.92M-118.56M3.54B-49.43M230.2M235.24M814.91M-1.85B2.56B992.24M-2.05B2.12B-1.74B-3.18B8.22B206.42M
Net Change in Cash-1.5B19.1B4.62B9.35B-25.99B25.32B-4.82B10.08B3.92B10.78B-15.87B1.52B3.84B24.03B6.71B-1.47B-533.68M3.22B1.57B-1.19B13.51B00-1.27B-1.39B-2.4B2.36B3.7B
Free Cash Flow-241.27B-20.01B2.97B51.09B30.98B7.62B10.19B9B9.52B22.77B24.41B23.96B5.52B11.89B-5.95B2.08B2.72B4.43B11.46B11.05B16.81B4.96B-8.68B-4.22B-1.35B141.5M-12.42B-2.32B
FCF Margin %-33.76%-3.08%0.49%8.9%4.56%1.35%2.24%2.2%2.52%7.9%8.86%8.16%2.12%5.49%-3.11%1.1%1.55%5.31%11.73%11.03%16.68%5.76%-12.01%-7.38%-2.95%0.37%-24.4%-6.99%
FCF Growth %-1145.13%-774.83%-94.2%64.87%306.45%-25.16%13.17%-5.43%-58.2%-6.71%1.87%334.33%-53.59%299.92%-386.29%-23.61%-38.61%-61.37%3.71%-34.25%238.83%157.15%-105.56%-213.48%-1052.13%101.14%-435.32%-
FCF per Share-107.10-9.031.3523.5014.333.494.754.224.4810.8811.7811.622.686.14-3.141.061.432.436.015.658.642.75-4.63-2.46-0.700.08-8.78-1.90
FCF Conversion (FCF/Net Income)-3.95x3.50x2.56x3.34x1.67x1.24x2.64x3.93x2.01x2.07x2.35x2.74x1.91x2.63x2.53x2.29x2.02x2.37x4.82x2.33x1.94x-4.36x4.60x4.85x87.67x-5.46x3.02x0.97x
Interest Paid000000000000001.89B1.52B1.39B1.66B1.72B000000000
Taxes Paid000000000000002.08B2.9B2.11B1.34B1.54B000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Capex intensity and margin dilution

Cash Conversion Diverges from Net Income

In 2026Q2, operating cash flow of $47.0B was 2.23 times net income of $21.1B, per the latest quarterly report, indicating high earnings quality despite heavy capex.

The OCF/NI ratio has consistently exceeded 2.0 in recent quarters, suggesting that reported net income is backed by strong cash generation, likely due to significant non-cash depreciation and amortization. However, the 2025Q4 quarter showed a negative OCF/NI of -0.37, which appears anomalous and may reflect working capital timing or one-off items. Investors should monitor whether this ratio remains elevated as capex accelerates.

FCF Turns Negative on Capex Surge

Free cash flow swung to -$32.8B in 2026Q2 from -$10.0B in 2026Q1, as capex reached 41.8% of revenue, according to reported figures, signaling aggressive investment.

The FCF margin deteriorated to -17.2% in 2026Q2, the worst in the series, driven by a sharp increase in capital expenditures to $79.8B. This aligns with the company's strategic pivot toward advanced packaging for AI, but it means that despite strong operating cash flow, the company is currently burning cash. The trajectory suggests that FCF will remain negative in the near term as capex intensity stays elevated, which may pressure liquidity if not offset by financing.

Capex Intensity Signals Growth Bet

Capital expenditure as a percentage of revenue jumped to 41.8% in 2026Q2 from 20.5% in 2024Q4, per financial statements, indicating a significant shift toward growth-oriented investment.

The capex-to-revenue ratio has more than doubled over the past year, with the absolute spend reaching $79.8B in 2026Q2. This appears to be directed at advanced packaging capacity for AI and HPC applications, as noted in recent context. While this may support future revenue growth, it also raises the risk of overcapacity if demand softens, and the high fixed-cost nature of the business means that underutilization could compress margins. The depreciation charge of $20.0B in 2026Q2 is rising, but it still lags the pace of capex, suggesting that future depreciation will increase and further pressure earnings.

Working Capital Volatility Masks Core Trends

Working capital changes swung from -$52.9B in 2025Q3 to +$1.4B in 2026Q2, based on reported cash flow data, indicating lumpy cash flow timing.

The working capital line has been highly volatile, with large negative changes in 2025Q3 and positive changes in other quarters. This may reflect the pass-through nature of materials in the EMS segment, which can distort cash flow timing. The recent positive changes in 2026Q1 and Q2 suggest that the company is managing collections and payables effectively, but the volatility warrants caution when interpreting quarterly cash flow trends. Investors should focus on the longer-term average to assess underlying working capital efficiency.

Capital Deployment Focused on Expansion

Dividends and buybacks were minimal in 2026, with only $2.5B in dividends paid in 2025Q4, while acquisitions totaled $1.1B in 2026Q1, per cash flow data, indicating reinvestment.

The company appears to be prioritizing capital expenditure over shareholder returns, with no buybacks in the last ten quarters and only sporadic dividend payments. The $98.7B dividend outflow in 2025Q3 is notable, but it may be a one-time distribution. The lack of consistent returns suggests that management is reinvesting heavily in growth, which aligns with the AI-driven capex strategy. However, if the investment does not generate expected returns, shareholders may see limited cash returns in the near term.

Cumulative Earnings Outpace Cash Flow

Over the last ten quarters, cumulative net income of $108.7B exceeds cumulative operating cash flow of $469.6B, per reported data, but the gap is driven by massive capex.

While operating cash flow has been robust, the cumulative free cash flow is deeply negative due to the extraordinary capital expenditure program. This divergence between earnings and free cash flow is a critical signal: the company is reinvesting heavily to capture future growth, but it is currently consuming cash. The sustainability of this strategy depends on the success of the advanced packaging investments. If they fail to generate adequate returns, the company may face cash flow strain, especially given the debt/equity ratio of 0.71.

What the Cash Flow Statement Obscures

The cash flow statement may understate true cash generation due to the pass-through nature of EMS materials and potential capitalization of costs, per industry norms, warranting scrutiny.

The EMS segment's pass-through revenue can inflate operating cash flow without contributing to profitability, potentially masking underlying cash generation quality. Additionally, the depreciation schedule for packaging equipment may be extended, which could overstate operating cash flow relative to actual replacement needs. Investors should examine the footnotes for capitalized costs and the useful life assumptions to assess whether reported cash flow is sustainable.

ASX — Frequently Asked Questions

Quick answers to the most common questions about buying ASX stock.

How much cash does ASE Technology Holding Co., Ltd. (ASX) generate from operations?

ASE Technology Holding Co., Ltd. (ASX) generated $143.03B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is ASE Technology Holding Co., Ltd.'s free cash flow?

ASE Technology Holding Co., Ltd. (ASX) reported negative free cash flow of $20.01B in 2025, indicating capital requirements exceeded cash from operations.

What is ASE Technology Holding Co., Ltd.'s capital expenditure (CapEx)?

ASE Technology Holding Co., Ltd. (ASX) spent $162.15B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does ASE Technology Holding Co., Ltd. distribute cash to shareholders?

In 2025, ASE Technology Holding Co., Ltd. (ASX) returned $23.16B to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.